Li Liu

Dr. Li Liu

College of Health Solution, Arizona State University, Scottsdale, AZ 85281, USA
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2024 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
JCJinhua Chi
Jinhua Chi
JSJingmin Shu
Jingmin Shu
MLMing Li
Ming Li
RMRekha Mudappathi
Rekha Mudappathi
YJYan Jin
Yan Jin
Haiwei GuHaiwei Gu
Haiwei Gu

13 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
YLYang Liu
Yang Liu
JFJia Fan
Jia Fan
TXTing Xu
Ting Xu
NANavid Ahmadinejad
Navid Ahmadinejad
KHKenneth Hess
Kenneth Hess
THTony Hu
Tony Hu
Extracellular vesicle Tspan8 levels in pretreatment serum from patients with NSCLC predict distant metastasis–free survival.

14 November 2019 in Bioinformatics
Verified
Journal Article
Open access
PDF file
PCPramod Chandrashekar
Pramod Chandrashekar
NANavid Ahmadinejad
Navid Ahmadinejad
JWJunwen Wang
Junwen Wang
ASAleksandar Sekulic
Aleksandar Sekulic
JEJan B Egan
Jan B Egan
Li LiuLi Liu
Li Liu
Functions of cancer driver genes vary substantially across tissues and organs. Distinguishing passenger genes, oncogenes (OGs) and tumor-suppressor genes (TSGs) for each cancer type is critical for understanding tumor biology and identifying clinically actionable targets. Although many computational tools are available to predict putative cancer driver genes, resources for context-aware classifications of OGs and TSGs are limited. We show that the direction and magnitude of somatic selection of protein-coding mutations are significantly different for passenger genes, OGs and TSGs. Based on these patterns, we develop a new method (genes under selection in tumors) to discover OGs and TSGs in a cancer-type specific manner. Genes under selection in tumors shows a high accuracy (92%) when evaluated via strict cross-validations. Its application to 10 172 tumor exomes found known and novel cancer drivers with high tissue-specificities. In 11 out of 13 OGs shared among multiple cancer types, we found functional domains selectively engaged in different cancers, suggesting differences in disease mechanisms. An R implementation of the GUST algorithm is available at https://github.com/liliulab/gust. A database with pre-computed results is available at https://liliulab.shinyapps.io/gust. Supplementary data are available at Bioinformatics online.

17 December 2012 in Retrovirology
Verified
Journal Article
Open access
PDF file
LYLi Yin
Li Yin
Li LiuLi Liu
Li Liu
YSYijun Sun
Yijun Sun
WHWei Hou
Wei Hou
ALAmanda C Lowe
Amanda C Lowe
MGMaureen M Goodenow
Maureen M Goodenow
Deep sequencing provides the basis for analysis of biodiversity of taxonomically similar organisms in an environment. While extensively applied to microbiome studies, population genetics studies of viruses are limited. To define the scope of HIV-1 population biodiversity within infected individuals, a suite of phylogenetic and population genetic algorithms was applied to HIV-1 envelope hypervariable domain 3 (Env V3) within peripheral blood mononuclear cells from a group of perinatally HIV-1 subtype B infected, therapy-naïve children.

1 January 2018 in Alzheimer's & Dementia: Translational Research & Clinical Interventions
Verified
Journal Article
Open access
Li LiuLi Liu
Li Liu
RCRichard J Caselli
Richard J Caselli
Introduction: The apolipoprotein E (APOE) e4 allele is a major genetic risk factor of late‐onset Alzheimer's disease. However, its interaction with two other canonical risk factors, age and sex, is not clear. Previous studies have reported conflicting results on its differential effects in men and women, its association with young‐onset AD before the age of 65 years, and its significance in genetic admixture populations. In these studies, the hazard of the e4 allele was assumed to be constant during aging. However, this hypothesis has not been tested and its violation may lead to significant biases and contribute to such discrepant findings. Methods: In a prospective cohort of 4727 subjects, we performed Cox regression analysis of the association of the e4 allele with AD age of onset. We then performed diagnostics on the resulting model and tested if the hazard of the e4 allele violated the assumption of proportionality during aging. We examined whether incorporating age stratifications and time‐dependent coefficients could restore the proportionality. We then validated our findings in four independent cohorts. Results: Hazard of the e4 allele for AD was nonproportional. It took a stepwise decline around the age of 80 years for men and around the age of 75 years for women. By stratifying subjects into a younger group and an older group, we detected more consistent effects of the e4 allele across multiple independent cohorts. We also found that the e4 allele was a significant risk factor for young‐onset AD with age of onset before 65 years. Discussion: Age compositions of study cohorts can significantly bias the estimated effect of the APOE genotype. Studies of AD should consider hidden age structures among subjects and routinely employ appropriate age and sex stratification strategies or nonparametric modeling in experimental designs and data analysis. Finally, we argue that the e4 allele is a risk factor not only for late‐onset AD but also for young‐onset AD.

1 January 2013 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
LYLi Yin
Li Yin
WHWei Hou
Wei Hou
Li LiuLi Liu
Li Liu
YCYunpeng Cai
Yunpeng Cai
MWMark Andrew Wallet
Mark Andrew Wallet
MGMaureen Michels Goodenow
Maureen Michels Goodenow
Background: HIV-1 infection or systemic lupus erythematosus [SLE] disrupt B cell homeostasis, reduce memory B cells, and impair function of IgG and IgM antibodies. Objective: To determine how disturbances in B cell populations producing polyclonal antibodies relate to the IgM repertoire, the IgM transcriptome in health and disease was explored at the complementarity determining region 3 [CDRH3] sequence population level. Methods: 454-deep pyrosequencing in combination with a novel analysis pipeline was applied to define populations of IGHM CDRH3 sequences based on absence or presence of somatic hypermutations [SHM] in peripheral blood B cells. Results: HIV or SLE subjects have reduced biodiversity within their IGHM transcriptome compared to healthy subjects, mainly due to a significant decrease in the number of unique combinations of alleles, although recombination machinery was intact. While major differences between sequences without or with SHM occurred among all groups, IGHD and IGHJ allele use, CDRH3 length distribution, or generation of SHM were similar among study cohorts. Antiretroviral therapy failed to normalize IGHM biodiversity in HIV-infected individuals. All subjects had a low frequency of allelic combinations within the IGHM repertoire similar to known broadly-neutralizing HIV-1 antibodies. Conclusions: Polyclonal expansion would decrease overall IgM biodiversity independent of other mechanisms for development of the B cell repertoire. Applying deep sequencing as a strategy to follow development of the IgM repertoire in health and disease provides a novel molecular assessment of multiple points along the B cell differentiation pathway that is highly sensitive for detecting perturbations within the repertoire at the population level.